drugset / Trial / NCT00333294

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

NCT00333294 ↗

Phase 2 Completed 50 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of this study is to determine wether the ZD1839 associated with a radiotherapy, before the beginning of chemotherapy is effective in the treatment of your disease and to evaluate the tolerance of these treatments.

Timeline

Start
2004-09
Primary completion
—
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Gefitinib Small molecule — —
Subject Vinorelbine Small molecule — —